Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.88 is in line with its 3-year average of 1.96, around the middle of its 3-year range (1.23–2.28).
As of the fiscal period ended Wednesday, December 31, 2025. 13.01% above its 12-month average of 1.66.
Reported quarterly current ratio; no daily interpolation. Q2 FY2025 (2025-12-31): 1.88.
CURRENT RATIO
1.88
CURRENT RATIO AVG TTM
1.66
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+13.01%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 798 covered companies
CURRENT VS SECTOR MEDIAN
-47.69%
vs the sector median at left
Basel Medical Group Ltd Ordinary Shares
Market Cap
$5.18M
Current Ratio
1.88
TTM Avg
1.66
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.16M
Current Ratio
1.12
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.12
Market Cap
$5.23M
Current Ratio
0.09
TTM Avg
0.18
3Y Avg
0.44
5Y Avg
0.97
Market Cap
$5.01M
Current Ratio
7.43
TTM Avg
7.85
3Y Avg
10.06
5Y Avg
11.10
Market Cap
$5.31M
Current Ratio
1.44
TTM Avg
1.10
3Y Avg
1.11
5Y Avg
1.95
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Basel Medical Group Ltd Ordinary Shares (BMGL) | $5.18M | 1.88 | 1.66 | N/A | N/A |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.16M | 1.12 | 0.07 | 0.07 | 0.12 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | 0.09 | 0.18 | 0.44 | 0.97 |
| Alzamend Neuro Inc (ALZN)vs › | $5.25M | 3.01 | 3.95 | 2.52 | 4.28 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.30M | 0.19 | 0.06 | 0.46 | 2.58 |
| Imunon, Inc. (IMNN)vs › | $5.04M | 1.82 | 1.99 | 2.53 | 3.43 |
| Xenetic Biosciences, Inc. (XBIO)vs › | $5.01M | 7.43 | 7.85 | 10.06 | 11.10 |
| Soligenix, Inc. (SNGX)vs › | $5.37M | 2.77 | 2.10 | 1.65 | 2.34 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.31M | 1.44 | 1.10 | 1.11 | 1.95 |
| Pulmatrix, Inc. (PULM)vs › | $5.41M | 4.70 | 11.62 | 9.04 | 8.74 |
Current Ratio
1.88
Quick Ratio
1.84
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 1.88 |
| 2025-06-30 | 1.23 |
| 2024-12-31 | 1.88 |
| 2024-06-30 | 2.26 |
| 2023-12-31 | 2.22 |
| 2023-06-30 | 2.28 |
